July 27, 2017/Cancer

How Do Older Adults Feel About Forgoing Cancer Screenings?

Study looks at doctor-patient communication on screenings

geriatric-patient_650x450

Cancer screenings are part of standard medical care, however, recent studies are showing that patients of advanced age or illness often do not benefit from this testing. A team at The Johns Hopkins University School of Medicine recently conducted a study to get a deeper understanding of older adults’ perspectives on screening cessation and communication with clinicians on this topic. Ronan Factora, MD, answers a few questions about study results.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Is this research important?

Discussions about cancer screening occur very frequently in the clinical setting, and knowledge of the kind of language that is most effective can help physicians refine their technique.

What is the key take home message from this study?

There were several take home messages. Patients state that their trust in the physician is the biggest influence on whether or not they agree with the physician’s recommendations to screen or not screen. We also learned that the use of the term “life expectancy” had limited usefulness to the patient. Health status seemed to be a more important factor for patients when making a decision to forgo further cancer screening. Patients preferred to hear statements like “this test is not going to help you live longer” or “this test is not going to be helpful,” rather than statements like “you are not going to live 10 years.”

Should the findings change patient management?

Yes. The perception of the patient in using terms such as “life expectancy” and “health status” should prompt physicians to avoid using terms that are misunderstood or ambiguous. Framing cancer screening discussions in the context of whether or not the screening will allow a patient to live longer appears to be more successful.

Advertisement

What are the study’s strongest points?

The study sampled individuals from a broad range of locations (ambulatory settings, home, primary care, internal medicine and geriatric medicine), and it is likely that patients seen at these locations would have similar perspectives. Individuals interviewed were 75 and older and were diverse so it was representative of the general population.

What are the main limitations of the study?

There were limited numbers of individuals involved, many of whom had a trusting relationship with their physicians. It is unclear if there would be similar results in a discussion with physicians that the patients did not know so well. The study also relied on self-reporting for the data, so responses to questions may not reflect how individuals would act in real life.

Though individuals with cognitive impairment were included in this study, many individuals with significant enough cognitive impairment require a surrogate decision maker to help them. It is unclear how surrogate decision makers would react to this discussion.

Advertisement

Go to PubMed Journals for more details and a link to JAMA for the full article.

Related Articles

Fluorescent imaging during small bowel surgery
April 11, 2024/Cancer/Surgical Oncology
Fluorescence Imaging Augments Surgical Inspection and Palpation for Small Bowel Carcinoid Tumors

Study demonstrates superior visualization of occult primary lesions

microwave ablation of liver tumor
150-Watt, Single-Antenna Microwave Ablation System Demonstrates Safety and Efficacy

New device offers greater tumor control for malignant liver lesions

viral-induced cancer
April 3, 2024/Cancer
Mechanism of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) May Serve as Clue to More Effective Treatment

Cleveland Clinic researchers discover what drives – and what may halt – virus-induced cancer

Dr. Mukherjee at Cleveland Clinic
April 1, 2024/Cancer/Blood Cancers
Many Patients with “Indolent” Systemic Mastocytosis Experience Rapid Decline and Lower Survival

First-ever U.S. population-level retrospective analysis reveals many patients with systemic mastocytosis need faster intervention

Cleveland Clinic physiatrist
March 22, 2024/Cancer/Innovations
The Vital Role of Oncology Rehabilitation (Podcast)

New program provides prehabilitation and rehabilitation services to help patients with cancer maintain and regain function

Doctors working on MGUS screening study
March 18, 2024/Cancer/Research
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Hematologist at Cleveland Clinic
March 14, 2024/Cancer/Blood Cancers
Advances in Mantle Cell Lymphoma Treatment (Podcast)

Global R&D efforts expanding first-line and relapse therapy options for patients

Physician with patient
March 6, 2024/Cancer/Research
Targeting Uncontrolled Erythrocytosis in Polycythemia Vera with Rusfertide

Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels

Ad